Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
7,758,979
-
Shares change
-
+2,889,218
-
Total reported value, excl. options
-
$15,984,132
-
Value change
-
+$6,005,853
-
Put/Call ratio
-
60%
-
Number of buys
-
36
-
Number of sells
-
-15
-
Price
-
$2.06
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q1 2025
68 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q1 2025.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,758,979 shares
of 27,407,170 outstanding shares and own 28.31% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1,209,545 shares), Schonfeld Strategic Advisors LLC (919,372 shares), Parkman Healthcare Partners LLC (781,670 shares), First Eagle Investment Management, LLC (724,519 shares), RENAISSANCE TECHNOLOGIES LLC (655,990 shares), BlackRock, Inc. (352,330 shares), Informed Momentum Co LLC (288,078 shares), GEODE CAPITAL MANAGEMENT, LLC (286,289 shares), Universal- Beteiligungs- und Servicegesellschaft mbH (245,033 shares), and CITADEL ADVISORS LLC (232,713 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.